The source code of LazyAct. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

Win rate vs Skip ratios on multi-agents tasks. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

Visualization on SMAC-25m based on <i>LazyAct</i>. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

Single agent and multi-agents tasks for <i>LazyAct</i>. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

Network architectures for multi-agents task. by Hongjie Zhang (136127)

“…Firstly, we incorporate a state skipping branch into the actor network to bypass states with minimal impact. …”

<b>Data used for analyses in the manuscript 'Sleep Regularity and Duration are Associated with Depression Severity in a Nationally Representative United States Sample'</b> by Katherine Maki (7445153)

“…</p><p dir="ltr"><b>Results: </b>Among participants (n=7297), we found associations between sleep-associated variables and SRI, with increased daytime sleep being the strongest correlate of decreased SRI. …”

Loss of parasympathetic cholinergic neurons innervating the liver. by Jiyeon Hwang (19747297)

“…(E, F) Summary plots showing a significant decrease in hepatic (control, <i>n</i> = 7 mice; experimental mice, <i>n</i> = 6 mice), but not plasma (control, <i>n</i> = 11 mice; experimental mice, <i>n</i> = 8 mice), ACh contents in ChAT^{Cre + AAVrg-FLEX-dtA} mice compared to the controls. …”

Table 1_Filtered and unfiltered lipoaspirates reveal novel molecular insights and therapeutic potential for osteoarthritis treatment: a preclinical in vitro study.docx by Alissa Behn (20793590)

“…Introduction<p>Orthobiologics, such as autologous nanofat, are emerging as a potential treatment option for osteoarthritis (OA), a common degenerative joint causing pain and disability in the elderly. …”

Supplementary file 1_Greening the start-up of reactive distillation: A combined experimental and LCA study from cold and empty state.pdf by Nikhil Sharma (571073)

“…The optimal start-up demonstrates a 64% reductions in start-up time compared to traditional start-up, which significantly reduces environmental impacts. …”

Supplementary Material for: Delayed Onset of Central Serous Chorioretinopathy (CSCR) following corticosteroid treatment for Giant Cell Arteritis (GCA): A Case Report by figshare admin karger (2628495)

“…Although the association between CSCR and corticosteroids is well established, its occurrence in patients diagnosed with GCA remains rarely reported in literature. Case Presentation: We present a case of a 71-year-old man who developed CSCR following six months of corticosteroid treatment for GCA. …”

Image 1_Anlotinib combined with tislelizumab in the treatment of primary small cell neuroendocrine carcinoma of the prostate: a case report and literature review.jpeg by Xin Fei (20466992)

“…The patient was then administered a combination of anlotinib and tislelizumab. After treatment, the patient’s symptoms were controlled, tumor marker levels decreased, and imaging showed significant improvement. …”

Data Sheet 1_Efgartigimod for generalized myasthenia gravis in the extreme elderly (≥80 years): a multicenter retrospective real-world study.pdf by Ye Hong (2580841)

“…At week 4 (1week after the final infusion), the study showed significant reductions in all efficacy measurements: MG-ADL scores decreased by 52.2% ± 30.8% (from 10.9 ± 2.7 to 3.6 ± 2.1), QMG scores by 36.6% ± 28.4% (from 18.2 ± 7.0 to 11.7 ± 8.3), MGC scores by 48.2% ± 33.4% (from 17.8 ± 7.5 to 9.0 ± 8.6). …”

Data Sheet 1_Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective stud... by Francesca Felicia Operto (12509263)

“…Among responders, 53.8% (14/26) achieved response on ≤100 mg/day, with CNBp of 0.5–17.6 μg/mL (median ∼5–6 μg/mL). There was no significant relationship between age and gender, although there was a statistically significant correlation between CNBp and BMI (p = 0.038; R2 = 0.157). …”

Data Sheet 1_A ROS-responsive, aptamer-targeted graphene oxide nanocomposite for site-specific glutathione release in cerebral ischemia-reperfusion injury.docx by Meiying Li (6051287)

“…In a Endothelin-1 (ET-1) induced cortical ischemia model, GO@GSH-FA led to a marked decrease in neurological deficit scores (from 7.20 ± 1.16 to 4.20 ± 0.98) and enhanced neuronal survival relative to untreated animals. …”

Supplementary file 1_Global burden of pulmonary sarcoidosis from 1990 to 2021: a comprehensive analysis based on the GBD 2021 study.xlsx by Jinming Cao (7837883)

“…Background and objective<p>Pulmonary sarcoidosis is a chronic respiratory disease with a growing global burden. …”

Supplementary file 4_Global burden of pulmonary sarcoidosis from 1990 to 2021: a comprehensive analysis based on the GBD 2021 study.xlsx by Jinming Cao (7837883)

“…Background and objective<p>Pulmonary sarcoidosis is a chronic respiratory disease with a growing global burden. …”

Table 1_Mental symptoms in post-COVID syndrome and post-COVID-19 vaccination syndrome: results of a representative population survey.docx by Andreas Czaplicki (21978866)

“…Although symptom profiles may overlap, comparative epidemiological data from the general population are limited.</p>Methods<p>We conducted a representative online survey of 4,632 adults in Germany and investigated mental symptoms associated with PCS and PCVS, including fatigue, cognitive problems, sleep disturbances, impaired performance and depressed mood. …”

Supplementary file 2_Global burden of pulmonary sarcoidosis from 1990 to 2021: a comprehensive analysis based on the GBD 2021 study.xlsx by Jinming Cao (7837883)

“…Background and objective<p>Pulmonary sarcoidosis is a chronic respiratory disease with a growing global burden. …”

Supplementary file 3_Global burden of pulmonary sarcoidosis from 1990 to 2021: a comprehensive analysis based on the GBD 2021 study.xlsx by Jinming Cao (7837883)

“…Background and objective<p>Pulmonary sarcoidosis is a chronic respiratory disease with a growing global burden. …”

Table 1_Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis.docx by Mohamed E. A. Mostafa (19834779)

“…</p>Results<p>The study found that ROSE-010 (100 µg) significantly lowered pain intensity in IBS patients compared to a placebo, with an overall odds ratio of 2.30, 95% CI: 1.53-3.46. …”